These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16261362)

  • 21. [Infants of drug-addicted mothers: pitfalls of replacement therapy].
    Vert P; Hamon I; Hubert C; Legagneur M; Hascoet JM
    Bull Acad Natl Med; 2008 May; 192(5):961-9; discussion 969. PubMed ID: 19238786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of methadone in healthy subjects and opiate users.
    Wolff K; Rostami-Hodjegan A; Shires S; Hay AW; Feely M; Calvert R; Raistrick D; Tucker GT
    Br J Clin Pharmacol; 1997 Oct; 44(4):325-34. PubMed ID: 9354306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program.
    Newman RG; Bashkow S; Calko D
    Am J Obstet Gynecol; 1975 Jan; 121(2):233-7. PubMed ID: 1115128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.
    Rook EJ; Hillebrand MJ; Rosing H; van Ree JM; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):213-21. PubMed ID: 16103023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    Hulse GK; O'Neil G; Arnold-Reed DE
    Int J Gynaecol Obstet; 2004 May; 85(2):170-1. PubMed ID: 15099783
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of adverse obstetric outcomes and maternity hospitalization among heroin-exposed and methadone-treated women in Taiwan.
    Chen CY; Lien YT; Yeh HH; Su LW; Ho IK
    Int J Drug Policy; 2015 Feb; 26(2):191-8. PubMed ID: 25171908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone and the pregnant user: a matter for careful clinical consideration.
    Hulse GK; O'Neill G
    Aust N Z J Obstet Gynaecol; 2001 Aug; 41(3):329-32. PubMed ID: 11592552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients.
    Mitchell TB; Dyer KR; Newcombe D; Somogyi AA; White JM
    Addict Biol; 2006 Jun; 11(2):170-4. PubMed ID: 16800831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women.
    Cleary BJ; Reynolds K; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
    Addiction; 2013 Apr; 108(4):762-70. PubMed ID: 23216809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.
    Schluger JH; Bart G; Green M; Ho A; Kreek MJ
    Neuropsychopharmacology; 2003 May; 28(5):985-94. PubMed ID: 12700714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.
    Pérez de los Cobos J; Siñol N; Trujols J; del Río E; Bañuls E; Luquero E; Menoyo A; Queraltó JM; Baiget M; Alvarez E
    Drug Alcohol Depend; 2007 Jul; 89(2-3):190-4. PubMed ID: 17234366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences].
    Hoell I; Havemann-Reinecke U
    Med Monatsschr Pharm; 2011 Oct; 34(10):363-74; quiz 375-6. PubMed ID: 22010420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal withdrawal syndrome in twins born to a mother on methadone substitution].
    Floch-Tudal C; Simonpoli AM; Montamat S; Couettoux MP; Crenn-Hebert C; Lejeune C
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B30-3. PubMed ID: 11104942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
    Vourvahis M; Wang R; Gruener DM; Bruce RD; Haider S; Tawadrous M
    Drug Alcohol Depend; 2012 Nov; 126(1-2):183-8. PubMed ID: 22682979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic.
    Ellwood DA; Sutherland P; Kent C; O'Connor M
    Aust N Z J Obstet Gynaecol; 1987 May; 27(2):92-8. PubMed ID: 3675451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves.
    Kell MJ
    J Addict Dis; 1995; 14(1):85-108. PubMed ID: 7632750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal stress from methadone withdrawal.
    Zuspan FP; Gumpel JA; Mejia-Zelaya A; Madden J; Davis R
    Am J Obstet Gynecol; 1975 May; 122(1):43-6. PubMed ID: 1130446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
    Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.